JANE STREET GROUP, LLC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G951. A total of 5 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2024$44,919,248
-9.7%
545,600
-4.2%
0.01%0.0%
Q1 2024$49,740,130
+1143.1%
569,500
+1272.3%
0.01%
+900.0%
Q4 2023$4,001,430
-60.5%
41,500
-63.8%
0.00%
-66.7%
Q3 2023$10,139,808
-75.4%
114,600
-75.9%
0.00%
-78.6%
Q2 2023$41,146,996
+627.1%
474,700
+715.6%
0.01%
+600.0%
Q1 2023$5,659,368
-60.8%
58,200
-58.2%
0.00%
-71.4%
Q4 2022$14,426,506
+40.5%
139,400
+15.1%
0.01%
+75.0%
Q3 2022$10,266,000
-18.6%
121,100
-20.4%
0.00%
-20.0%
Q2 2022$12,613,000152,2000.01%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q2 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 70,100$5,923,0000.05%
BOOTHBAY FUND MANAGEMENT, LLC 68$574,0000.05%
SIMPLEX TRADING, LLC 697$5,889,0000.01%
Worth Venture Partners, LLC 12,100$15,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders